Business Description
Britannia Life Sciences Inc
NAICS : 541714
SIC : 3741
ISIN : CA11042D1087
Compare
Compare
Traded in other countries / regions
BLAB.CanadaL020.Germany IPO Date
2017-12-07Description
Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.09 | |||||
| Debt-to-Equity | 3.61 | |||||
| Debt-to-EBITDA | -1.86 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.71 | |||||
| Beneish M-Score | -4.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.7 | |||||
| 3-Year EPS without NRI Growth Rate | -80.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.51 | |||||
| 9-Day RSI | 49 | |||||
| 14-Day RSI | 48.8 | |||||
| 6-1 Month Momentum % | -24.14 | |||||
| 12-1 Month Momentum % | -13.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.23 | |||||
| Quick Ratio | 0.21 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 22.57 | |||||
| Days Sales Outstanding | 77.65 | |||||
| Days Payable | 422.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.9 | |||||
| Shareholder Yield % | 17.09 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.96 | |||||
| Operating Margin % | -60.21 | |||||
| Net Margin % | -73 | |||||
| FCF Margin % | 17.73 | |||||
| ROE % | -97.18 | |||||
| ROA % | -23.42 | |||||
| ROIC % | -17.93 | |||||
| ROC (Joel Greenblatt) % | -614.73 | |||||
| ROCE % | -26.05 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.65 | |||||
| PB Ratio | 2.5 | |||||
| Price-to-Free-Cash-Flow | 3.75 | |||||
| Price-to-Operating-Cash-Flow | 3 | |||||
| EV-to-EBIT | -3.34 | |||||
| EV-to-EBITDA | -3.66 | |||||
| EV-to-Revenue | 1.83 | |||||
| EV-to-FCF | 8.49 | |||||
| Earnings Yield (Greenblatt) % | -29.86 | |||||
| FCF Yield % | 17.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Britannia Life Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.048 | ||
| EPS (TTM) (€) | -0.025 | ||
| Beta | 0 | ||
| Volatility % | 106.74 | ||
| 14-Day RSI | 48.8 | ||
| 14-Day ATR (€) | 0.005756 | ||
| 20-Day SMA (€) | 0.014675 | ||
| 12-1 Month Momentum % | -13.73 | ||
| 52-Week Range (€) | 0.005 - 0.066 | ||
| Shares Outstanding (Mil) | 162.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Britannia Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Britannia Life Sciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Britannia Life Sciences Inc Frequently Asked Questions
What is Britannia Life Sciences Inc(FRA:L020)'s stock price today?
The current price of FRA:L020 is €0.02. The 52 week high of FRA:L020 is €0.07 and 52 week low is €0.01.
When is next earnings date of Britannia Life Sciences Inc(FRA:L020)?
The next earnings date of Britannia Life Sciences Inc(FRA:L020) is .
Does Britannia Life Sciences Inc(FRA:L020) pay dividends? If so, how much?
Britannia Life Sciences Inc(FRA:L020) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers